What is the recommended Human Papillomavirus (HPV) vaccine schedule?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HPV Vaccine Schedule Recommendations

Routine HPV vaccination should be initiated at age 11-12 years, though it can be started as early as age 9 years, with a 2-dose schedule for those beginning before age 15 and a 3-dose schedule for those starting at age 15 or older. 1

Age-Based Dosing Schedules

For Children and Young Adolescents (Starting Before Age 15)

  • Administer 2 doses total when vaccination begins before the 15th birthday 1
  • Give the second dose 6-12 months after the first dose 1, 2
  • The critical factor is the age when the first dose was given, not when subsequent doses are administered 1
  • If the first dose is given at age 14, only one more dose is needed at least 6 months later, regardless of when the second dose is actually given 1

For Older Adolescents and Adults (Starting at Age 15 or Older)

  • Administer 3 doses total when vaccination begins at age 15 or older 1, 3
  • Follow the schedule: 0,1-2, and 6 months 1, 3
  • Minimum intervals: 4 weeks between doses 1 and 2, and 12 weeks between doses 2 and 3 1, 2
  • Maintain at least 24 weeks between doses 1 and 3 3

Catch-Up Vaccination

  • Vaccinate all persons through age 26 years who are not adequately vaccinated 1, 3
  • For ages 27-45 years, use shared clinical decision-making considering individual risk factors, though effectiveness may be lower due to likely prior HPV exposure 3

Special Populations Requiring 3 Doses

Immunocompromised Individuals

  • Always use a 3-dose schedule regardless of age at initiation for those with immunocompromising conditions 1, 3
  • Be aware that immune response and vaccine efficacy may be reduced compared to immunocompetent individuals 3

Men Who Have Sex With Men

  • Vaccinate through age 26 years if not previously vaccinated 1

Managing Interrupted Series

Never restart the vaccination series if interrupted 1, 3, 2. Instead:

  • Continue from where you left off 1, 3
  • Maintain minimum intervals: 4 weeks between doses 1-2, and 12 weeks between doses 2-3 1, 2
  • Longer intervals between doses may actually produce stronger immune responses than shorter intervals 1

Pregnancy and Breastfeeding

  • Do not vaccinate during pregnancy; postpone subsequent doses until after delivery 1, 3
  • Breastfeeding women can safely receive the vaccine 1, 3

Administration Considerations

Syncope Prevention

  • Have patients sit or lie down for 15 minutes after vaccination, as syncope can occur in adolescents following injections 1, 2

Co-Administration

  • HPV vaccine can be given at the same visit as other age-appropriate vaccines (Tdap, MCV4) using separate syringes at different anatomic sites 1

Critical Clinical Pitfalls to Avoid

Do Not Delay Vaccination

  • Do not wait for "optimal" timing once the patient is eligible 1, 3
  • Approximately 24% of adolescents report sexual intercourse by 9th grade, and HPV infection incidence is nearly 60% within 2 years after sexual initiation in males 1, 2

Prior Sexual Activity Is Not a Contraindication

  • Vaccinate sexually active individuals according to age-based recommendations 1, 3
  • A history of genital warts, abnormal Pap test, or positive HPV DNA test does not mean the person has been infected with all vaccine HPV types 3
  • The vaccine will still protect against other vaccine HPV types not yet acquired 1, 3

Screening Must Continue

  • Cervical cancer screening recommendations have not changed for vaccinated individuals 1, 3
  • The vaccine does not protect against all oncogenic HPV types 1, 3

Contraindications

  • History of immediate hypersensitivity to yeast or any vaccine component 1
  • Defer vaccination for moderate or severe acute illness 1

No Pre-Vaccination Testing Required

  • Do not perform HPV testing before vaccination 1

References

Guideline

HPV Vaccination Schedule Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

HPV Vaccination Schedule and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

HPV Vaccine Schedule and Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.